Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs)

Published:2004-09 Issue:3 Volume:45 Page:325-337
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Ishii Haruhiko,Yazawa Takuya,Sato Hanako,Suzuki Takehisa,Ikeda Masaichi,Hayashi Yasufumi,Takanashi Yoshinori,Kitamura Hitoshi

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference51 articles.

1. The biology of vascular endothelial growth factor;Ferrara;Endocr. Rev.,1997

2. Vascular endothelial growth factor (VEGF) and its receptors;Neufeld;FASEB J.,1999

3. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice;Jeltsch;Science,1997

4. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses;Rissanen;Circ. Res.,2003

5. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development;Gale;Genes Dev.,1999

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malignant pleural disease;Breathe;2023-12

2. Clinical importance of serum and pleural fluid prominin-1 and hypoxia-inducible factor-1α concentration in the evaluation of lymph node involvement in patients with malignant pleural effusion;Biochemia medica;2023-10-13

3. Comparison between different treatment regimens of vascular targeting drug to malignant pleural effusion in patients with lung cancer: A Bayesian network meta-analysis;Medicine;2023-07-21

4. Malignant Pleural Effusions in the Era of Immunotherapy and Antiangiogenic Therapy;Seminars in Respiratory and Critical Care Medicine;2023-06-12

5. Evaluation of Light's criteria in cytologically proved malignant pleural effusions;Minerva Medica;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3